{"id":53597,"date":"2023-02-02T23:02:41","date_gmt":"2023-02-02T22:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/"},"modified":"2023-02-02T23:02:41","modified_gmt":"2023-02-02T22:02:41","slug":"gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/","title":{"rendered":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend"},"content":{"rendered":"
\n

FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD<\/a>–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company\u2019s Board of Directors has declared an increase of 2.7% in the company\u2019s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on March 30, 2023, to stockholders of record at the close of business on March 15, 2023. Future dividends will be subject to Board approval.\n<\/p>\n

<\/a><\/p>\n

\nAbout Gilead Sciences<\/span><\/b>\n<\/p>\n

\nGilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:
\n
<\/span><\/b>Jacquie Ross, CFA
\n
investor_relations@gilead.com<\/a>\n<\/p>\n

\nMedia:
\n
<\/span><\/b>Ashleigh Koss
\n
public_affairs@gilead.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company\u2019s Board of Directors has declared an increase of 2.7% in the company\u2019s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53597","6":"format-standard","7":"category-industry"},"yoast_head":"\nGilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company\u2019s Board of Directors has declared an increase of 2.7% in the company\u2019s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T22:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend\",\"datePublished\":\"2023-02-02T22:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201006125\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/\",\"name\":\"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201006125\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"datePublished\":\"2023-02-02T22:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201006125\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201006125\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend","og_description":"FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company\u2019s Board of Directors has declared an increase of 2.7% in the company\u2019s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T22:02:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend","datePublished":"2023-02-02T22:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/"},"wordCount":170,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/","url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/","name":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg","datePublished":"2023-02-02T22:02:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230201006125\/en\/778437\/21\/GCP_Primarylarge_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-2-7-percent-increase-in-first-quarter-2023-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53597"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53597\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}